Research & Education
CURE Expert Connections
CURE Speaking Out
Email Sign Up
Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL!
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
See all >
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
See all >
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Choosing the Best Therapy for Patients with Chronic Lymphocytic Leukemia
With many targeted treatment options for patients with CLL to use upfront, the question arises as to which one is best for the individual.
Limiting Treatment Duration Improves Cost Effectiveness in CLL
Dr. Matthew Davids
Researchers are exploring ways to limit the duration of treatment in chronic lymphocytic leukemia in order to reduce costs.
Clinical Trial Participants May Fare Better Than Medicare Beneficiaries Treated with Zydelig
Kristie L. Kahl
Those with follicular lymphoma and chronic lymphocytic leukemia who were treated with Zydelig in the clinical setting experienced less favorable outcomes, compared with those treated in a clinical trial.
A Look Back at the Top 10 CURE Stories of 2019
As 2019 comes to a close, take a read through
®’s top stories of the year.
MDM2 Inhibitor Shows Promise For Patients With AML
Naval Daver, MD
New findings show that a wider study is needed for MDM2 inhibitors in treating patients with AML.
Don't Ignore Your Wake-Up Call
When one woman experienced symptoms of chronic lymphocytic leukemia, people blamed her nerves and told her to rest. Instead, she listened to her body.
Investigational Oral Chemotherapy Boosts Survival in Older Patients with AML
Patients aged 55 and over remained in remission after receiving CC-486, according to phase 3 study findings.
Genomic Sequencing Could Individualize Diagnosis, Treatment of Myeloid Cancers
Beth Fand Incollingo
Whole genome sequencing of blood and bone marrow from patients with acute myeloid leukemia and myelodysplastic syndrome has revealed previously unknown disease subtypes.
Immunotherapy Is Superior to Chemotherapy for Children and Young Adults with Relapsed B-Acute Lymphoblastic Leukemia
In a phase 3 clinical trial, Blincyto (blinatumomab), a type of immunotherapy, improved survival and showed fewer side effects in young patients.
Ibrutinib and Rituximab Improve Progression-Free Survival for Patients with CLL
Results presented at ASH 2019 suggest the combination therapy is superior to chemoimmunotherapy.
Not a member?
Sign up now!
Continue without login